(PDF) 66 Clinical Validity of New Genetic Biomarkers of

66 Clinical Validity of New Genetic Biomarkers of Irinotecan Neutropenia: An Independent Replication Study

European Journal of Cancer - United Kingdom

doi 10.1016/s0959-8049(14)70192-3

Full Text

Abstract

Available in full text

Categories

Cancer Research

Date

November 1, 2014

Authors

R.H.N. van Schaik

R.H.J. Mathijssen

Publisher

Elsevier BV

Related search

Clinical Validity of New Genetic Biomarkers of Irinotecan Neutropenia: An Independent Replication Study

Pharmacogenomics Journal

Molecular Medicine

English

Comprehensive Pharmacogenetic Analysis of Irinotecan Neutropenia and Pharmacokinetics

Journal of Clinical Oncology

Cancer Research

English

The Patient Care Monitor-Neutropenia Index: Development, Reliability, and Validity of a Measure for Chemotherapy-Induced Neutropenia

Oncology Nursing Forum

English

Application of the Gross Motor Function Measure-66 (GMFM-66) in Dutch Clinical Practice: A Survey Study

English

Clinical Implications of Pretreatment Inflammatory Biomarkers as Independent Prognostic Indicators in Prostate Cancer

Journal of Clinical Laboratory Analysis

Medical Laboratory Technology

Clinical Biochemistry

Occupational Health

English

Models for Chromosomal Replication-Independent Non-B DNA Structure-Induced Genetic Instability

Molecular Carcinogenesis

Cancer Research

Molecular Biology

English

Prediction of Dementia Risk in Low-Income and Middle-Income Countries (The 10/66 Study): An Independent External Validation of Existing Models

The Lancet Global Health

English

Independent Candidate Serum Protein Biomarkers of Response to Adalimumab and to Infliximab in Rheumatoid Arthritis: An Exploratory Study

Multidisciplinary

English

Validity of Clinical Diagnosis in Dementia: A Prospective Clinicopathological Study.

Journal of Neurology, Neurosurgery and Psychiatry

English